Consistent with a previous report4, the mRNA expression levels of KLF4 were significantly higher in differentiated monocytes than that in AML cells, suggesting that induction of the expression levels of KLF4 could be a therapeutic strategy for patients with AML (Fig. 1A). The gene discussed is KLF4; the disease is acute myeloid leukemia.